Fondazione Penta Ets

Respiratory Syncytial Virus Prevention in Infants

Research activity in RSV focuses on infant protection strategies aimed at reducing symptomatic infection during early life, with attention to maternal and infant immunisation approaches and passive antibody-based prevention.

  • Infant RSV immunisation
  • Maternal vaccination
  • Monoclonal antibody prophylaxis

The work spans collaborative sites across multiple European countries and centres on preventive care for vulnerable infants.

Paediatric HIV Treatment

Clinical research in HIV infection addresses maintenance of viral control in children, with interest in antiretroviral combinations suitable for paediatric use and simplified treatment options.

  • Virological suppression
  • Dolutegravir-based regimens
  • Lamivudine-containing therapy

The paediatric focus highlights therapeutic management for children living with HIV across routine clinical settings.

Want to learn more about this study or check if you can participate? Contact us.

Matched clinical trials

  • Study of RSV vaccine and nirsevimab combination to prevent RSV infection in infants up to 12 months of age

    Not yet recruiting

    1 1 1 1
    Investigated diseases:
    Belgium The Netherlands
  • Study on Dolutegravir and Lamivudine for Maintaining Viral Control in Children with HIV Aged 2 to Under 15 Years

    Not recruiting

    1 1 1 1
    Spain